BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28245091)

  • 1. SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome model.
    Connelly S; Bristol JA; Hubert S; Subramanian P; Hasan NA; Colwell RR; Kaleko M
    J Appl Microbiol; 2017 Jul; 123(1):66-79. PubMed ID: 28245091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Metallo-Beta-Lactamase Protects the Gut Microbiome From Carbapenem-Mediated Damage and Reduces Propagation of Antibiotic Resistance in Pigs.
    Connelly S; Fanelli B; Hasan NA; Colwell RR; Kaleko M
    Front Microbiol; 2019; 10():101. PubMed ID: 30804903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Beta-Lactamase Protects the Canine Gut Microbiome from Oral Amoxicillin-Mediated Damage.
    Connelly S; Fanelli B; Hasan NA; Colwell RR; Kaleko M
    Microorganisms; 2019 May; 7(5):. PubMed ID: 31137766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SYN-007, an Orally Administered Beta-Lactamase Enzyme, Protects the Gut Microbiome from Oral Amoxicillin/Clavulanate without Adversely Affecting Antibiotic Systemic Absorption in Dogs.
    Connelly S; Fanelli B; Hasan NA; Colwell RR; Kaleko M
    Microorganisms; 2020 Jan; 8(2):. PubMed ID: 31979034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.
    Kokai-Kun JF; Roberts T; Coughlin O; Sicard E; Rufiange M; Fedorak R; Carter C; Adams MH; Longstreth J; Whalen H; Sliman J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone.
    Kokai-Kun JF; Le C; Trout K; Cope JL; Ajami NJ; Degar AJ; Connelly S
    Infect Drug Resist; 2020; 13():2521-2535. PubMed ID: 32801790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose oral beta-lactamase protects the gut microbiome from oral beta-lactam-mediated damage in dogs.
    Connelly S; Fanelli B; Hasan NA; Colwell RR; Kaleko M
    AIMS Public Health; 2019; 6(4):477-487. PubMed ID: 31909068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, Characterization, and Formulation of a Novel Carbapenemase Intended to Prevent Antibiotic-Mediated Gut Dysbiosis.
    Connelly S; Parsley T; Ge H; Kaleko M
    Microorganisms; 2019 Jan; 7(1):. PubMed ID: 30654495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial.
    Kokai-Kun JF; Roberts T; Coughlin O; Le C; Whalen H; Stevenson R; Wacher VJ; Sliman J
    Lancet Infect Dis; 2019 May; 19(5):487-496. PubMed ID: 30885591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection.
    Kaleko M; Bristol JA; Hubert S; Parsley T; Widmer G; Tzipori S; Subramanian P; Hasan N; Koski P; Kokai-Kun J; Sliman J; Jones A; Connelly S
    Anaerobe; 2016 Oct; 41():58-67. PubMed ID: 27262694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct consequences of amoxicillin and ertapenem exposure in the porcine gut microbiome.
    Connelly S; Subramanian P; Hasan NA; Colwell RR; Kaleko M
    Anaerobe; 2018 Oct; 53():82-93. PubMed ID: 29689301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon.
    Bristol A; Hubert S; Hofmann F; Baer H
    Int J Pharm; 2017 Dec; 534(1-2):25-34. PubMed ID: 28986322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonclinical Safety Assessment of SYN-004: An Oral β-lactamase for the Protection of the Gut Microbiome From Disruption by Biliary-Excreted, Intravenously Administered Antibiotics.
    Kokai-Kun JF; Bristol JA; Setser J; Schlosser M
    Int J Toxicol; 2016 May; 35(3):309-16. PubMed ID: 26700136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Antibiotic Treatment with Piperacillin/Tazobactam versus Ceftriaxone on the Composition of the Murine Gut Microbiota.
    Venturini C; Bowring B; Fajardo-Lubian A; Devine C; Iredell J
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Pig Gut Microbiome and Antibiotic Resistome in Industrialized Feedlots in China.
    Wang C; Li P; Yan Q; Chen L; Li T; Zhang W; Li H; Chen C; Han X; Zhang S; Xu M; Li B; Zhang X; Ni H; Ma Y; Dong B; Li S; Liu S
    mSystems; 2019 Dec; 4(6):. PubMed ID: 31848308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial recovery of microbiomes after antibiotic treatment.
    Raymond F; Déraspe M; Boissinot M; Bergeron MG; Corbeil J
    Gut Microbes; 2016 Sep; 7(5):428-34. PubMed ID: 27494088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies.
    Roberts T; Kokai-Kun JF; Coughlin O; Lopez BV; Whalen H; Bristol JA; Hubert S; Longstreth J; Lasseter K; Sliman J
    Clin Drug Investig; 2016 Sep; 36(9):725-734. PubMed ID: 27283946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The initial state of the human gut microbiome determines its reshaping by antibiotics.
    Raymond F; Ouameur AA; Déraspe M; Iqbal N; Gingras H; Dridi B; Leprohon P; Plante PL; Giroux R; Bérubé È; Frenette J; Boudreau DK; Simard JL; Chabot I; Domingo MC; Trottier S; Boissinot M; Huletsky A; Roy PH; Ouellette M; Bergeron MG; Corbeil J
    ISME J; 2016 Mar; 10(3):707-20. PubMed ID: 26359913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.
    Rosenfeld CS
    Front Cell Infect Microbiol; 2017; 7():396. PubMed ID: 28936425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demystifying Dysbiosis: Can the Gut Microbiome Promote Oral Tolerance Over IgE-mediated Food Allergy?
    Marrs T; Sim K
    Curr Pediatr Rev; 2018; 14(3):156-163. PubMed ID: 29732975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.